Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial - JIMG March 2023

Description

Among patients taking potentially cardiotoxic chemotherapy for cancer, the 3-year data show improvement of LV dysfunction compared with 1 year, with no difference in ΔEF between GLS- and EF-guided CPT.

Editors
Editor-in-Chief
Y.S. Chandrashekhar, MD, DM, FACC

CME Editor
Ragavendra R. Baliga, MD

Author
Yevgeniy Khariton, MD

Important Dates
Date of Release: March 6, 2023
Term of Approval/Date of CME/MOC Expiration: March 5, 2024

Summary


Availability:	On-Demand
	Expires on Mar 05, 2024


Cost:	FREE

Credit Offered:

1 CME Credit

1 ABIM-MOC Point